ResMed | RMD - Cost Of Sales

Stock Price
271.63
Daily Change
4.58 1.72%
Monthly
9.44%
Yearly
14.64%
Q1 Forecast
250.35

ResMed reported $555.85M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Ansell USD 254.1M 232.2M Jun/2024
AtriCure USD 32.94M 1.72M Sep/2025
Baxter International USD 1.88B 66M Sep/2025
Cochlear AUD 158.85M 131.25M Jun/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
CSL USD 1.79B 2.15B Jun/2025
Dexcom USD 477.9M 9.6M Sep/2025
Edwards Lifesciences USD 345.2M 800K Sep/2025
Fisher Paykel Healthcare NZD 402.8M 15.2M Dec/2025
Globus Medical USD 282.38M 3.42M Sep/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
Insulet USD 196.2M 700K Sep/2025
Integra LifeSciences USD 195.07M 11.2M Sep/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
Masimo USD 140.9M 3.3M Sep/2025
Medtronic USD 3.52B 80M Sep/2025
Philips EUR 2.39B 65M Sep/2025
Ramsay Health Care AUD 2.98B 742.1M Jun/2025
ResMed USD 555.85M 29.13M Dec/2025
Sigma Healthcare AUD 1.55B 165.16M Dec/2024
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Steris USD 840.7M 26.3M Dec/2025
Teleflex USD 461.38M 111.57M Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025